Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Brooks Laboratories Ltd

NSE: BROOKS · BSE: 533543 · Pharmaceuticals & Biotechnology · 19 announcements

Share price
₹58.78
Market cap
₹173.2 Cr
Revenue (annual)
₹85.74 Cr
Net profit (annual)
₹24.58 Cr
P/E (TTM)
13.1×Sector 47.3×
Promoter holding
52.62%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:14 IST BSE
Other Announcement

Brooks Laboratories Other Announcement

Brooks Laboratories is informing shareholders about the availability of the Annual Report for FY 2025-26 and requesting KYC updates in compliance with regulatory requirements.

15:14 IST BSE
Other Announcement

Brooks Laboratories Other Announcement

Brooks Laboratories Limited filed its shareholding pattern as per Regulation 31(1)(b). The filing details holdings across promoters, institutions, and public shareholders.

20:31 IST BSE
Other Announcement

Brooks Laboratories Other Announcement

Brooks Laboratories filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with no new material deviations.

11:46 IST NSE
Other Announcement

Brooks Laboratories Other Announcement

Atul Ranchal, promoter of Brooks Laboratories Ltd, submitted a declaration under SEBI Takeover Regulations for FY 2025-26. The filing confirms that the promoter and promoter group made no new share encumbrances during the year, other than those already disclosed. This is a routine annual regulatory compliance disclosure.

Execution
Financial Year 2025-26